within Pharmacolibrary.Drugs.ATC.L;

model L04AK01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.82,
    Cl             = 7.833333333333333e-07,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.009699999999999999,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.001,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.00222,
    k12             = 0.102,
    k21             = 0.102
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>L04AK01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Leflunomide is an immunomodulatory agent classified as a disease-modifying antirheumatic drug (DMARD). It works primarily by inhibiting dihydroorotate dehydrogenase, thus blocking pyrimidine synthesis, and is used in the treatment of rheumatoid arthritis and psoriatic arthritis. It is approved and widely used today for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters of leflunomide (its active metabolite A77 1726) in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Singer, LM, et al., &amp; Papich, MG (2011). Leflunomide pharmacokinetics after single oral administration to dogs. <i>Journal of veterinary pharmacology and therapeutics</i> 34(6) 609–611. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2885.2011.01275.x&quot;>10.1111/j.1365-2885.2011.01275.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21995753/&quot;>https://pubmed.ncbi.nlm.nih.gov/21995753</a></p></li><li><p>Li, J, et al., &amp; Xu, SY (2002). Pharmacokinetics of leflunomide in Chinese healthy volunteers. <i>Acta pharmacologica Sinica</i> 23(6) 551–555. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12060531/&quot;>https://pubmed.ncbi.nlm.nih.gov/12060531</a></p></li><li><p>Mehl, ML, et al., &amp; Gregory, CR (2012). Pharmacokinetics and pharmacodynamics of A77 1726 and leflunomide in domestic cats. <i>Journal of veterinary pharmacology and therapeutics</i> 35(2) 139–146. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2885.2011.01306.x&quot;>10.1111/j.1365-2885.2011.01306.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21615755/&quot;>https://pubmed.ncbi.nlm.nih.gov/21615755</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end L04AK01;
